Research Article
The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study
Table 1
Distribution of cases according to the Bethesda system.
| Bethesda category | Bethesda category percentage (%) | FNA diagnosis | No. of cases (total = 646) | Percentage (%) |
| I—nondiagnostic (89) | 13.8 | Cyst fluid | 6 | 0.9 | Scant cellularity | 50 | 7.8 | Obscuring blood | 33 | 5.1 | II—benign (490) | 75.9 | Nodular goitre | 224 | 34.7 | Adenomatoid nodule | 37 | 5.7 | Colloid nodule | 70 | 10.8 | Grave’s disease | 3 | 0.5 | Lymphocytic (Hashimoto) thyroiditis | 156 | 24.2 | III—AUS/FLUS (8) | 1.2 | AUS/FLUS | 8 | 1.2 | IV—FN/SFN (24) | 3.7 | FN/SFN | 24 | 3.7 | V—suspicious for malignancy (17) | 2.6 | Suspicious for papillary carcinoma | 16 | 2.4 | Suspicious for medullary carcinoma | 1 | 0.2 | VI—malignant (18) | 2.8 | Papillary carcinoma | 13 | 2.0 | Medullary carcinoma | 3 | 0.4 | Poorly differentiated carcinoma | 1 | 0.2 | Undifferentiated carcinoma | 1 | 0.2 |
|
|